Medical News

RSS

Transplantation of human mononuclear cells exerts a deleterious effect in rats with liver cirrhosis

The use of stem cells in regenerative medicine is not always beneficial for human health, it may even be harmful according to a work done by the universities of Granada and León. Scientists have demonstrated that transplantation of human mononuclear cells isolated from umbilical cord blood exerted a deleterious effect in rats with liver cirrhosis.

12 Nov 2009

Congressional Democrats seeking to maintain health overhaul momentum

The Senate could begin debate next week on a health care reform bill while House Democratic leadership is telling members to prepare to work deep into December.

12 Nov 2009

Predictive power of Champions Biotechnology's Biomerk Tumorgraft platform to be presented

Champions Biotechnology, Inc., an oncology drug development company with a predictive preclinical platform aimed at accelerating the development and enhancing the value of oncology drugs, has announced that two of its studies regarding its application in oncology drug development and personalized medicine have been selected for a poster and oral presentation at the upcoming AACR-EORTC conference in Boston.

12 Nov 2009

Abortion rights groups unite in fight against coverage restrictions

Politico reports that abortion-rights "advocates are calling in the cavalry to help fight off an anti-abortion provision House Democratic leaders swallowed in order to win passage of their health care reform bill."

12 Nov 2009

Second-quarter fiscal 2010 results announced by AdvanSource Biomaterials

AdvanSource Biomaterials Corporation, a leading developer of advanced polymer materials for a broad range of medical devices, today announced financial results for its fiscal 2010 second quarter ended September 30, 2009.

12 Nov 2009

Will the health bill bend costs?

One cause for health reform anxiety is that no one is sure whether the legislation would achieve one of its most critical goals: lowering health care costs.

12 Nov 2009

Making end-of-life wishes known is rare; more hospice care could save Medicare money

Because Medicare beneficiaries account "for the vast majority of U.S. deaths" the treatment people receive "in the last year of life accounts for roughly a quarter of Medicare's budget." Dr. Joel Policzer, a medical director for a hospice, says that often "a dying elderly patient may have wanted less invasive care. But it doesn't happen.

12 Nov 2009

Pharmos announces financial results for the third quarter of 2009

Pharmos Corporation today reported financial results for the third quarter and nine-month period ended September 30, 2009.

12 Nov 2009

Activists worry immigration arguments will hamper hispanic health care

The Washington Post reports that Hispanic lawmakers and groups are "scrambling to develop a strategy to counter what they see as efforts to shortchange immigrants in health bills on Capitol Hill."

12 Nov 2009

Childhood exposure to environmental pollutants could impact development in the long-term

Children who eat fish more than 3 times per week show a worse performance in the general cognitive, executive and perceptual-manipulative areas. Those with higher levels of exposure to mercury show a generalised delay in cognitive, memory and verbal areas. Mercury is a contaminant found especially in oily fish and canned fish and to a lesser extent in white fish.

12 Nov 2009

Birner Dental Management Services reports financial results for the quarter ended September 30, 2009

Birner Dental Management Services, Inc., operators of PERFECT TEETH dental practices, announced results for the quarter and nine months ended September 30, 2009. For the quarter ended September 30, 2009, total dental group practice revenue decreased $285,000 or 1.9% to $14.7 million. Net revenue decreased $268,000, or 3.1%, to $8.5 million.

12 Nov 2009

HUD threatens to block Washington D.C.'s AIDS funding

The U.S. Department of Housing and Urban Development is threatening to halt federal funding for the Washington D.C.'s AIDS programs after a Washington Post investigation found many delivered faulty services and failed to account for their work.

12 Nov 2009

New Cat B 750 FAST imaging agent launched by VisEn Medical

VisEn Medical Inc., a leader in fluorescence in vivo imaging from research through medicine, announced today the commercial launch of its new Cat B 750 FAST(TM) imaging agent for measuring and monitoring cathepsin B activity associated with disease progression and therapeutic response in vivo. Cathepsin B expression is well known as a key biomarker and therapeutic target in a range of diseases, including atherosclerosis, oncology, and arthritis.

12 Nov 2009

Today's selection of opinions and editorials

After months of discussion and debate, the House has passed its version of health care reform. But as many observers, including me, have already noted, health care reform has primarily become health insurance reform over the course of the year (Gail Wilensky, 11/12).

12 Nov 2009

Third-quarter 2009 results announced by Neurologix

Neurologix, Inc., a biotechnology company engaged in the development of innovative gene therapies for the brain and central nervous system, announced today its financial results for the third quarter and nine months ended September 30, 2009.

12 Nov 2009

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

3M Health Care and Zargis Medical, a majority-owned subsidiary of Speedus Corp. (Nasdaq:SPDE), announced today that the 3M™ Littmann® Electronic Stethoscope Model 3200 with Zargis Cardioscan™ software was named Popular Science’s “Innovation of the Year.” This prestigious honor, part of the publication’s annual “Best of What’s New Awards,” highlights outstanding innovation, vision and execution in technologic, scientific and medical advances for the year.

12 Nov 2009

Biostar Pharmaceuticals reports financial results for the third quarter of 2009

Biostar Pharmaceuticals, Inc., a Xianyang-based developer, manufacturer and supplier of pharmaceutical products and medical nutrients addressing a variety of diseases and conditions, today announced financial results the third quarter ended September 30, 2009.

12 Nov 2009

arGentis Pharmaceuticals to commence human clinical evaluation of ARG301 oral altered peptide ligand

arGentis Pharmaceuticals, LLC today announced that it will collaborate with the University of Tennessee Health Science Center (UTHSC) and the Veterans Affairs Medical Center of Memphis (VAMC) to initiate the first human clinical evaluation of an oral altered peptide ligand (APL), ARG301, in a Phase I study of Rheumatoid Arthritis patients.

12 Nov 2009

Third-quarter 2009 results announced by Catalyst Pharmaceutical

Catalyst Pharmaceutical Partners, Inc. today reported financial results for the third quarter and nine months ended September 30, 2009.

12 Nov 2009

American Medical Alert announces operating results for the third quarter of 2009

American Medical Alert Corp. a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and nine months ended September 30, 2009.

12 Nov 2009

Medical News

Transplantation of human mononuclear cells exerts a deleterious effect in rats with liver cirrhosis

Congressional Democrats seeking to maintain health overhaul momentum

Predictive power of Champions Biotechnology's Biomerk Tumorgraft platform to be presented

Abortion rights groups unite in fight against coverage restrictions

Second-quarter fiscal 2010 results announced by AdvanSource Biomaterials

Will the health bill bend costs?

Making end-of-life wishes known is rare; more hospice care could save Medicare money

Pharmos announces financial results for the third quarter of 2009

Activists worry immigration arguments will hamper hispanic health care

Childhood exposure to environmental pollutants could impact development in the long-term

Birner Dental Management Services reports financial results for the quarter ended September 30, 2009

HUD threatens to block Washington D.C.'s AIDS funding

New Cat B 750 FAST imaging agent launched by VisEn Medical

Today's selection of opinions and editorials

Third-quarter 2009 results announced by Neurologix

Innovation of the Year: Littmann Electronic Stethoscope Model 3200 with Zargis Cardioscan software

Biostar Pharmaceuticals reports financial results for the third quarter of 2009

arGentis Pharmaceuticals to commence human clinical evaluation of ARG301 oral altered peptide ligand

Third-quarter 2009 results announced by Catalyst Pharmaceutical

American Medical Alert announces operating results for the third quarter of 2009

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News